Suppr超能文献

表达LAG-3的肿瘤浸润性T细胞与胰腺癌无病生存期缩短相关。

LAG-3-Expressing Tumor-Infiltrating T Cells Are Associated with Reduced Disease-Free Survival in Pancreatic Cancer.

作者信息

Seifert Lena, Plesca Ioana, Müller Luise, Sommer Ulrich, Heiduk Max, von Renesse Janusz, Digomann David, Glück Jessica, Klimova Anna, Weitz Jürgen, Schmitz Marc, Seifert Adrian M

机构信息

Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, TU Dresden, 01307 Dresden, Germany.

National Center for Tumor Diseases (NCT), Partner Site Dresden, 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2021 Mar 15;13(6):1297. doi: 10.3390/cancers13061297.

Abstract

T cells are the predominant immune cell population in the pancreatic tumor microenvironment. High CD8 and Th1-polarized CD4 T cell infiltration is associated with prolonged survival in human pancreatic ductal adenocarcinoma (PDAC). However, the expression pattern of co-stimulatory and inhibitory receptors by PDAC-infiltrating T cells and their prognostic significance are not well defined. In this study, we employed multiplex immunofluorescence to investigate the intratumoral expression of the co-stimulatory receptor inducible T-cell co-stimulator (ICOS), the inhibitory receptors lymphocyte-activation gene 3 (LAG-3), programmed death 1 (PD-1), and V-domain immunoglobulin suppressor of T cell activation (VISTA) by tumor-infiltrating T cells (CD3) in a cohort of 69 patients with resected PDAC. T cells were enriched particularly within the stromal area and were highly heterogeneous across tumors. Further, T cells were associated with prolonged disease-free survival (DFS). However, LAG-3 expression by PDAC-infiltrating T cells was correlated with reduced DFS. Our study highlights the biological importance of LAG-3 expression by tumor-infiltrating T cells. LAG-3 T cells may represent a novel prognostic marker and a particularly attractive target for immunotherapeutic strategies in PDAC.

摘要

T细胞是胰腺肿瘤微环境中主要的免疫细胞群体。高CD8和Th1极化的CD4 T细胞浸润与人胰腺导管腺癌(PDAC)患者的生存期延长相关。然而,PDAC浸润性T细胞共刺激和抑制性受体的表达模式及其预后意义尚不清楚。在本研究中,我们采用多重免疫荧光法,对69例接受手术切除的PDAC患者肿瘤浸润性T细胞(CD3)中共刺激受体诱导性T细胞共刺激分子(ICOS)、抑制性受体淋巴细胞激活基因3(LAG-3)、程序性死亡1(PD-1)和T细胞激活V结构域免疫球蛋白抑制分子(VISTA)的瘤内表达情况进行了研究。T细胞尤其富集于基质区域,且在不同肿瘤之间具有高度异质性。此外,T细胞与无病生存期(DFS)延长相关。然而,PDAC浸润性T细胞中LAG-3的表达与DFS缩短相关。我们的研究突出了肿瘤浸润性T细胞表达LAG-3的生物学重要性。LAG-3阳性T细胞可能代表一种新的预后标志物,是PDAC免疫治疗策略中一个特别有吸引力的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0997/7998134/bf3cad6496d4/cancers-13-01297-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验